111In-DTPA-A20FMDVran

N/A

Report date: 2025/11/11 17:59:39

Base Information

Drug Name111In-DTPA-A20FMDVran

Drug Alias Name111In-DTPA-A20FMDVran

ClassificationRadiation-emitting products > Nuclides > Indium > 111InRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionIntegrin alpha-V/beta-6 binders

TargetsIntegrin alpha-V/beta-6

Therapy Area/IndicationsPulmonary Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Nottingham

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Nottingham

Inactive CompaniesN/A

Active IndicationsPulmonary Fibrosis

Inactive IndicationsN/A

Other Information

ATC CodeN/A